Baby

CDC Announces Release of Over 77,000 Additional Doses of Beyfortusâ„¢ for RSV Protection in Infants

The Centers for Disease Control and Prevention (CDC) has recently announced the release of more than 77,000 additional doses of Beyfortusâ„¢ (nirsevimab-alip (100 mg)), a long-acting monoclonal antibody designed to …

CDC Announces Release of Over 77,000 Additional Doses of Beyfortusâ„¢ for RSV Protection in Infants Read More